To analyze visual acuity and visual quality after implantation of Zeiss 839 and Zeiss 809.

In this retrospective study, a total of 54 patients (83 eyes) who underwent phacoemulsification were reviewed from August 2017 to January 2019. Twenty-eight patients (42 eyes) were implanted with Zeiss 839 trifocal lenses (839 group), and 26 patients (41 eyes) were implanted with Zeiss 809 bifocal lenses (809 group). Uncorrected visual acuity as well as visual quality were analyzed by the OQAS at 1 week, 1 month and 3 months postoperatively, and the defocus curve and the results of the questionnaire survey at 3 months postoperatively were compared between the two groups. A Paired-sample t test and repeated measures analysis of variance were used to analyze the data.

The 839 group had better distance uncorrected visual acuity (UCVA) 1 month and 3 months postoperatively, and better intermediate UIVA at each observation time point than the 809 group (both P<0.05). The OSI, MTF cutoff, SR, PVA100%, PVA20% and PVA9% were not significantly different between the 839 group and 809 group postoperatively. The defocus curve showed that the wave form of the 839 group was more stable and higher in the range of -3 to -1 D. The incidence of glare, light and dark visual adaptation, independent spectacle ratio and satisfaction in the 839 group and 809 group were 2%vs. 7%, 93% vs. 88%, 98% vs. 78%, 90% vs. 85%, respectively.

The trifocal IOL and bifocal IOL have excellent uncorrected near and distance vision and superior visual quality. Zeiss 839 has excellent middle distance vision, a higher independent spectacle ratio and better satisfaction.

intraocular lens; visual acuity; optical quality; independent spectacles ratio